Previous 10 | Next 10 |
SEATTLE, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that clonoSEQ ® ...
2023-09-12 17:27:39 ET Gainers: Rocket Pharmaceuticals ( RCKT ) +30% . Alset Capital Acquisition ( ACAX ) +14% . Veeco Instruments ( VECO ) +7% . InnovAge Holding ( INNV ) +4% . Fulcrum Therapeutics ( FULC ) +4% ...
SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...
2023-08-02 22:38:05 ET Adaptive Biotechnologies Corporation (ADPT) Q2 2023 Results Conference Call August 02, 2023 04:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - CEO and Co-founder Tycho Peterson - CFO Nitin Sood - Chief Commercia...
2023-08-02 16:45:25 ET Adaptive Biotechnologies press release ( NASDAQ: ADPT ): Q2 GAAP EPS of -$0.33 beats by $0.01 . Revenue of $48.9M (+11.9% Y/Y) beats by $4.01M . Revenue was $48.9 million for the quarter ended June 30, 2023, representing a 12% increase fr...
SEATTLE, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...
2023-07-21 17:17:13 ET Gainers: Gritstone bio ( GRTS ) +4.8% . LexinFintech Holdings ( LX ) +4.3% . AppLovin ( APP ) +2.9% . Latham Group ( SWIM ) +2.6% . Accuray ( ARAY ) +2.5% . Losers: ALX Oncology Holdings ( ALXO ...
SEATTLE, July 10, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...
2023-07-07 14:00:03 ET Summary Shares of diagnostics and drug discovery concern Adaptive Biotechnologies Corporation have crashed over 90% as the commercial-stage concern struggles with profitability. On the top line, the company’s clonoSEQ test volume increased 57% year-ov...
2023-07-01 01:55:50 ET Summary Adapt Biotechnologies comes with interesting core offerings in immune medicine. The firm's MRD segment is driving the bulk of sales upsides, backed by sales volumes of its immunoSEQ and clonoSEQ units. Looking forward, ADPT reiterates its full-ye...
News, Short Squeeze, Breakout and More Instantly...
Adaptive Biotechnologies Corporation Company Name:
ADPT Stock Symbol:
NASDAQ Market:
Adaptive Biotechnologies Corporation Website:
SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial...
SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation sequen...
SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating ...